UBS’s IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN XXV Stock Holding History

UBS’s Portfolio XXV Stock Details XXV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$170K	Sell	4,430 -3	-0.1%	-$115	﹤0.01%	5362
2014 Q2	$171K	Sell	4,433 -1,003	-18%	-$38.6K	﹤0.01%	5309
2014 Q1	$209K	Buy	5,436 +40	+0.7%	+$1.54K	﹤0.01%	5145
2013 Q4	$208K	Sell	5,396 -660	-11%	-$25.4K	﹤0.01%	5260
2013 Q3	$232K	Sell	6,056 -1,650	-21%	-$63.4K	﹤0.01%	5009
2013 Q2	$294K	Buy	+7,706	New	+$295K	﹤0.01%	4671

Other funds holding XXV

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS's XXV Position: Q3 2014 in Review

UBS reduced its IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) stake by 0.07% in Q3 2014, selling an estimated $115 and leaving 4,430 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #5362.

UBS first reported a position in XXV in Q2 2013 and has held it in 6 quarters since. The position peaked at $294K in Q2 2013. 3 funds tracked by Wall St. Rank hold XXV as of Q3 2014.

UBS held 4,430 shares of IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN worth $170K as of Q3 2014.
UBS sold 3 IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN shares in Q3 2014, an estimated $115.
IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5362 holding.
UBS first reported a position in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN in Q2 2013 and has held it in 6 quarters since.
UBS's IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN position peaked at $294K in Q2 2013.
3 funds tracked by Wall St. Rank held IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.